The pandemic ushered in delays in routine cancer screening in the U.S.

However, increases in the time since patients’ last routine cancer screening had already been increasing since before 2020, according to a study in JAMA Network Open. The study also found that the decrease in cancer screening prevalence was even greater in populations of lower socioeconomic status. These findings underscore important opportunities for intervention, messaging, and innovation to make routine cancer screening more accessible and worthwhile for patients.